Cite
The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
MLA
Fei Cao, et al. “The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.” Frontiers in Oncology, vol. 11, Dec. 2021. EBSCOhost, https://doi.org/10.3389/fonc.2021.783480.
APA
Fei Cao, Yi Yang, Tongguo Si, Jun Luo, Hui Zeng, Zhewei Zhang, Duiping Feng, Yi Chen, & Jiaping Zheng. (2021). The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.783480
Chicago
Fei Cao, Yi Yang, Tongguo Si, Jun Luo, Hui Zeng, Zhewei Zhang, Duiping Feng, Yi Chen, and Jiaping Zheng. 2021. “The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.” Frontiers in Oncology 11 (December). doi:10.3389/fonc.2021.783480.